➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Medtronic
Boehringer Ingelheim
Merck
McKesson

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

SOMAVERT Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for SOMAVERT

Identify potential brand extensions & biosimilar entrants

SponsorPhase
St. Michael's Hospital, TorontoPhase 3
Erasmus Medical CenterPhase 4
NovartisPhase 4

See all SOMAVERT clinical trials

Recent Litigation for SOMAVERT

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Supernus Pharmaceuticals, Inc v. Actavis Inc.2016-02-23

See all SOMAVERT litigation

Company Disclosures: US Patents for SOMAVERT

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 001 2003-03-25   Try Before You Buy Genentech, Inc. (South San Francisco, CA) 2015-09-21 RX company
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 002 2003-03-25   Try Before You Buy Genentech, Inc. (South San Francisco, CA) 2015-09-21 RX company
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 003 2003-03-25   Try Before You Buy Genentech, Inc. (South San Francisco, CA) 2015-09-21 RX company
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 004 2003-03-25   Try Before You Buy Genentech, Inc. (South San Francisco, CA) 2015-09-21 RX company
Pharmacia SOMAVERT pegvisomant INJECTABLE;SUBCUTANEOUS 021106 005 2003-03-25   Try Before You Buy Genentech, Inc. (South San Francisco, CA) 2015-09-21 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for SOMAVERT

These patents were identified by searching patent claims

International Patents for SOMAVERT

Country Patent Number Estimated Expiration
Singapore 10201606784Q   Try Before You Buy
Canada 2230492   Try Before You Buy
Japan WO2015046482   Try Before You Buy
World Intellectual Property Organization (WIPO) 9004788   Try Before You Buy
South Korea 20160062023   Try Before You Buy
World Intellectual Property Organization (WIPO) 2010071817   Try Before You Buy
South Korea 101794052   Try Before You Buy
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for SOMAVERT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 43/2005 Austria   Try Before You Buy PRODUCT NAME: PEGVISOMANT
268 Finland   Try Before You Buy
SPC029/2005 Ireland   Try Before You Buy SPC029/2005: 20061023, EXPIRES: 20171112
91204 Luxembourg   Try Before You Buy 91204, EXPIRES: 20171113
132006901381900 Italy   Try Before You Buy AUTHORISATION NUMBER(S) AND DATE(S): EU/1/02/240/001-003, 20021113
C00851925/01 Switzerland   Try Before You Buy FORMER REPRESENTATIVE: BOVARD AG PATENTANWAELTE, CH
05C0043 France   Try Before You Buy PRODUCT NAME: PEGVISOMANT; REGISTRATION NO/DATE: EU/1/02/240/001-003 20021113
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Harvard Business School
Moodys
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.